Table 2.
Treatment with SDD and tobramycin serum concentrations
| Patient | SDD (orally and via gastric tube) | SDD suppositories | Days on SDD | Tobramycin serum concentrations (mg/l) |
|---|---|---|---|---|
| 1 | + | – | 24 | < 0.2 |
| + | – | 27 | 0.2 | |
| 2 | + | – | 3 | 0.2 |
| + | – | 6 | 1.1 | |
| + | – | 10 | 1.7 | |
| 3 | + | + | 6 | 0.5 |
| + | + | 9 | 0.5 | |
| 4 | + | – | 3 | 0.2 |
| 5 | + | – | 3 | < 0.2 |
| 6 | + | – | 19 | < 0.2 |
| 7 | + | – | 6 | < 0.2 |
| 8 | + | – | 9 | 0.7 |
| 9 | + | – | 6 | 0.3 |
| 10 | + | – | 6 | 0.2 |
| 11 | + | – | 6 | < 0.2 |
| 12 | + | – | 3 | 3.0 |
| 13 | + | – | 3 | 0.2 |
| 14 | + | + | 9 | < 0.2 |
| 15 | + | + | 3 | 1.1 |
| 16 | + | – | 3 | < 0.2 |
| + | – | 6 | 0.3 | |
| 17 | + | – | 7 | < 0.2 |
| + | – | 9 | < 0.2 | |
| 18 | + | – | 6 | < 0.2 |
| + | – | 9 | < 0.2 | |
| 19 | + | – | 6 | 1.0 |
< 0.2: below quantification limit